Cargando…
TUG1/MAZ/FTH1 Axis Attenuates the Antiglioma Effect of Dihydroartemisinin by Inhibiting Ferroptosis
Glioma is the most common primary intracranial malignant tumor in the brain. Currently, due to the limited treatment methods, the clinical outcome of patients with standard surgery combined with radiotherapy and chemotherapy is not satisfactory. Therefore, we urgently need to develop effective drugs...
Autores principales: | Gong, Hailong, Gao, Mingjun, Lin, Yuancai, Liu, Jinliang, Hu, Zhiwen, Liu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509247/ https://www.ncbi.nlm.nih.gov/pubmed/36164395 http://dx.doi.org/10.1155/2022/7843863 |
Ejemplares similares
-
HECW1 induces NCOA4-regulated ferroptosis in glioma through the ubiquitination and degradation of ZNF350
por: Lin, Yuancai, et al.
Publicado: (2023) -
Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1
por: Kong, Na, et al.
Publicado: (2021) -
The NSUN5-FTH1/FTL pathway mediates ferroptosis in bone marrow-derived mesenchymal stem cells
por: Liu, Jie, et al.
Publicado: (2022) -
Trametinib Inhibits the Growth and Aerobic Glycolysis of Glioma Cells by Targeting the PKM2/c-Myc Axis
por: Gao, Mingjun, et al.
Publicado: (2021) -
Inhibiting Ferroptosis through Disrupting the NCOA4–FTH1
Interaction: A New Mechanism of Action
por: Fang, Yuying, et al.
Publicado: (2021)